As of 2026-05-26, the EV/EBITDA ratio of Karuna Therapeutics Inc (KRTX) is -25.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KRTX's latest enterprise value is 12,397.19 mil USD. KRTX's TTM EBITDA according to its financial statements is -492.49 mil USD. Dividing these 2 quantities gives us the above KRTX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 16.0x | 14.8x |
| Forward P/E multiples | 17.3x - 20.3x | 19.3x |
| Fair Price | (217.94) - (201.68) | (215.23) |
| Upside | -166.1% - -161.1% | -165.3% |
| Date | EV/EBITDA |